Theophylline (Theophylline GDC, Theolair Liquid, Nuelin SA, Nuelin Liquid)
Theophylline
Gulf Drug Company (Pty) Ltd
Registration
- Applicant
- Gulf Drug Company (Pty) Ltd
- Registrations
- 5
Variants
| Product | Strength and form | Registration | Status | Schedule | Leaflets |
|---|---|---|---|---|---|
| Theophylline 200 GDC EACH TABLET CONTAINS THEOPHYLLINE 200,0 mg | 200 | 33041633/10.2/0416 | Registered | Not determined | None |
| Theophylline 300 GDC EACH TABLET CONTAINS THEOPHYLLINE 300,0 mg | 300 | 33041733/10.2/0417 | Registered | Not determined | None |
| Theolair liquid Each 5,0 ml Liquid contains: Theophylline 25,0 mg | 25 mg/5 mlLiquid | 51107151/10.2/1071Approved 13 May 2021 | Registered | Not determined | PIPIL |
| Nuelin SA EACH TABLET CONTAINS : THEOPHYLLINE 250 mg | 250 mgTablet. | P0054P/10.2/54Approved 10 April 2022 | Registered | Not determined | PIPIL |
| Nuelin liquid EACH 5,0 ml LIQUID CONTAINS:THEOPHYLLINE 25,0 mg | 25 mg/5 mlLiquid | S0126S/10.2/126Approved 13 May 2021 | Registered | Not determined | PIPIL |
Regulatory status
This product is still scheduled by law even when this site could not determine which tier it falls under. The label carries the S number in a square border; ask a pharmacist if you need to know its schedule.
Listings for this ingredient that could not be applied to this product
S4: Theophylline
- and its derivatives, unless listed elsewhere in the Schedules, and preparations intended for injection. (S2)
Consolidated Schedules 06 July 2026, lines 8173 to 8174
S2: Theophylline
- and its derivatives, unless listed in another Schedule, and except in preparations for injection.
Consolidated Schedules 06 July 2026, line 2723
This is an informational summary of the Medicines and Related Substances Act 101 of 1965 and its 2017 General Regulations. It is not medical advice and not legal advice. Always check the medicine's label, which carries the schedule number inside a square border, or ask a pharmacist if you are unsure.
1,3-Dimethyl-7H-purine-2,6-dione
Drag to rotate. Structure from PubChem CID 2153.
SAHPRA documents
These documents are provided by SAHPRA for informational purposes. Always consult with a healthcare professional for medical advice.